Efficacy and safety of belimumab in the treatment of systemic lupus erythematosus: A meta‑analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of belimumab in the treatment of systemic lupus erythematosus: A meta‑analysis

Published:2022-02-07 Issue:2 Volume:4 Page:
ISSN:2632-2900
Container-title:World Academy of Sciences Journal
language:
Short-container-title:World Acad Sci J

Author:

Zhang Jiachen¹,Liu Xiangying²,Xu Yan³,Li Hongyan³,Xu Yuexia³

Affiliation:

1. Department of Nephrology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang 317000, P.R. China

2. Department of Nephrology, Changzhou Geriatric Hospital Affiliated to Soochow University, Changzhou No. 7 People's Hospital, Changzhou, Jiangsu 213000, P.R. China

3. Department of Nephrology, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, Jiangsu 215200, P.R. China

Publisher

Spandidos Publications

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology

Reference50 articles.

1. The Asia-pacific league of associations for rheumatology consensus statements on the management of systemic lupus erythematosus;Mok;Lancet Rheumatol,2021

2. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases;Cheema;Arthritis Rheum,2001

3. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome;Groom;J Clin Invest,2002

4. Breaking the ice in systemic lupus erythematosus: Belimumab, a promising new therapy;Mosak;Lupus,2013

5. B lymphocyte stimulator (BLyS): A therapeutic trichotomy for the treatment of B lymphocyte diseases;Nardelli;Leuk Lymphoma,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP